CEL SCI CORP — Director's Dealing 2017

Jul 25, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CEL SCI CORP (cvm)
CIK: 0000725363
Period of Report: 2017-07-24

Reporting Person: KERSTEN GEERT R (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-24	Convertible Note	$2.29	A	109170	Acquired	2017-12-22	Common Stock (109170)	Indirect
2017-07-24	Series NN Warrant	$2.52	A	109170	Acquired	2022-07-24	Common Stock (109170)	Indirect

Footnotes

F1: A trust in which Mr. Kersten holds a beneficial interest participated in an offering and purchased a note in the principal amount of $250,000 as well the Series NN warrant. Shares issuable upon the conversion of the notes or exercise of the warrant will be restricted securities unless registered. The number of securities beneficially owned gives effect to the 25-for-1 reverse stock split which became effective on June 15, 2017, and include Series N warrants (as amended) to purchase 85,339 shares of common stock held by the de Clara Trust. The amended Series N warrants expire on August 18, 2018 and are exercisable at a price of $3.00 per share.